GANX — Gain Therapeutics Share News
0.000.00%
Last trade - 00:00U.S. STOCKS ON THE MOVE- Commvault Systems, Rockwell Automation, Tesla
U.S. STOCKS ON THE MOVE-Commvault Systems, Rockwell Automation, Tesla
Gain Therapeutics falls on pricing stock-and-warrants offering
Gain Therapeutics falls on equity offering plans
Brief: Gain Therapeutics Completes Target Enrollment in Phase 1b GT-02287 Study for Parkinson’s with or without GBA1 Mutation
Gain Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary
Gain Therapeutics Inc expected to post a loss of 18 cents a share - Earnings Preview
Brief: Gain Therapeutics Announces Oral Poster Presentation
Gain Therapeutics Inc reports results for the quarter ended December 31 - Earnings Summary
Gain Therapeutics Inc expected to post a loss of 18 cents a share - Earnings Preview
Brief: Gain Therapeutics Forms Clinical Advisory Board To Support Continued Advancement Of Lead Drug Candidate GT-02287
Gain Therapeutics Inc reports results for the quarter ended September 30 - Earnings Summary
Gain Therapeutics Inc expected to post a loss of 21 cents a share - Earnings Preview
Gain Therapeutics Inc reports results for the quarter ended in January - Earnings Summary
Gain Therapeutics Inc expected to post a loss of 20 cents a share - Earnings Preview
Brief: Gain Announces Completion Of Dosing In Multiple Ascending Dose Of Phase 1 Study Of GT-02287, Therapy For Parkinson’s Disease
Brief: Gain Therapeutics, Inc. Appoints Gene Mack As Interim CEO
Brief: Gain Therapeutics Announces Pricing Of $11.0 Million Public Offering
Brief: Gain Therapeutics Announces Proposed Public Offering